Fresenius Medical Care AG & Co. KGaA announced that it has reached a settlement in principle to end an investigation of possible FCPA violations. The company disclosed in its regulatory filing that it has recorded charges of € 224 million encompassing estimates for the government’s claims for profit disgorgement, penalties, and incurred and expected legal expenses, impairments, and costs.
February 20, 2019
German dialysis equipment supplier reaches settlement in principle with US authorities in FCPA probe
Related by Topic
DOJ’s Newly Established National Fraud Enforcement Division Announces New Structure and Five Priority Enforcement Areas
August 18, 2026
Insight
Federal jury finds former executive guilty of violating the FCPA
August 11, 2026
News Alert